WHO ICTRP trial
Efficacy and Safety of Interferon-alpha1b (IFN-a1b) Injection into Foramen in…
ChiCTR2400089962 · Chinese Clinical Trial Registry (ChiCTR) · Recruiting
Key facts
| Trial ID | ChiCTR2400089962 |
|---|---|
| Public title | Efficacy and Safety of Interferon-alpha1b (IFN-a1b) Injection into Foramen in Patients with Postherpetic Neuralgia: a Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial |
| Scientific title | Efficacy and Safety of Interferon-alpha1b (IFN-a1b) Injection into Foramen in Patients with Postherpetic Neuralgia: a Randomized, Double-Blind, Placebo-Controlled, Multicenter Clinical Trial |
| Primary sponsor | China-Japan Friendship Hospital |
| Registry | Chinese Clinical Trial Registry (ChiCTR) |
| Recruitment status | Recruiting |
| Study type | Interventional study |
| Phase | 4 |
| Countries | China |
| Conditions | Postherpetic Neuralgia |
| Interventions | Treatment group:IFN-a1b injection into foramen in combination with conventional therapy ;Control group:Placebo injection into foramen in combination with conventional therapy |
| Registration date | Sep 20, 2024 |
| Target size | Treatment group:100;Control group:100 |
| Registry page | chictr.org.cn |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: